Omada Health, Inc. Gross Profit
Omada Health, Inc. (OMDA) reported Gross Profit of $63.79 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-07.
Financial Statements › Income Statement
us-gaap:GrossProfit · last filed 2026-08-07
- Omada Health, Inc. gross profit for the quarter ending 2026-06-30 was $63.79M, a 58.26% increase year-over-year.
- Omada Health, Inc. gross profit for the quarter ending 2026-03-31 was $48.69M, a 52.64% increase year-over-year.
- Omada Health, Inc. gross profit for the quarter ending 2025-12-31 was $53.66M, a 67.00% increase year-over-year.
- Omada Health, Inc. gross profit for the quarter ending 2025-09-30 was $45.07M, a 57.80% increase year-over-year.
- Omada Health, Inc. gross profit for fiscal 2025 was $170.94M, a 66.16% increase from fiscal 2024.
- Omada Health, Inc. gross profit for fiscal 2024 was $102.88M, a 47.03% increase from fiscal 2023.
- Omada Health, Inc. gross profit for fiscal 2023 was $69.97M.
| Period end | Gross Profit 3 month | Gross Profit 6 month | Gross Profit 9 month | Gross Profit 12 month |
|---|---|---|---|---|
| 2026-06-30 | $63.79M 10-Q · filed 2026-08-07 | $112.48M 10-Q · filed 2026-08-07 | $166.14M derived: sum of 3 quarters · filed 2026-08-07 | $211.21M derived: sum of 4 quarters · filed 2026-08-07 |
| 2026-03-31 | $48.69M 10-Q · filed 2026-05-08 | $102.36M derived: sum of 2 quarters · filed 2026-05-08 | $147.43M derived: sum of 3 quarters · filed 2026-05-08 | $187.73M derived: sum of 4 quarters · filed 2026-08-07 |
| 2025-12-31 | $53.66M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-06 | $98.73M derived: sum of 2 quarters · filed 2026-03-06 | $139.04M derived: sum of 3 quarters · filed 2026-08-07 | $170.94M 10-K · filed 2026-03-06 |
| 2025-09-30 | $45.07M 10-Q · filed 2025-11-07 | $85.38M derived: sum of 2 quarters · filed 2026-08-07 | $117.28M 10-Q · filed 2025-11-07 | $149.41M derived: sum of 4 quarters · filed 2026-08-07 |
| 2025-06-30 | $40.31M 10-Q · filed 2026-08-07 | $72.21M 10-Q · filed 2026-08-07 | $104.34M derived: sum of 3 quarters · filed 2026-08-07 | $132.90M derived: sum of 4 quarters · filed 2026-08-07 |
| 2025-03-31 | $31.90M 10-Q · filed 2026-05-08 | $64.03M derived: sum of 2 quarters · filed 2026-05-08 | $92.59M derived: sum of 3 quarters · filed 2026-05-08 | $117.43M derived: sum of 4 quarters · filed 2026-05-08 |
| 2024-12-31 | $32.13M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-06 | $60.70M derived: sum of 2 quarters · filed 2026-03-06 | $85.53M derived: sum of 3 quarters · filed 2026-03-06 | $102.88M 10-K · filed 2026-03-06 |
| 2024-09-30 | $28.56M 10-Q · filed 2025-11-07 | $53.40M derived: sum of 2 quarters · filed 2025-11-07 | $70.74M 10-Q · filed 2025-11-07 | |
| 2024-06-30 | $24.83M 10-Q · filed 2025-08-08 | $42.18M 10-Q · filed 2025-08-08 | ||
| 2023-12-31 | $69.97M 10-K · filed 2026-03-06 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| InnovAge Holding Corp. (INNV) | United States | $1.206B | -635.60 |
| U S PHYSICAL THERAPY INC /NV (USPH) | United States | $1.251B | 32.48 |
| Pennant Group, Inc. (PNTG) | United States | $1.386B | 39.84 |
| Strata Critical Medical, Inc. (SRTA) | United States | $0.467B | 11.33 |
| DocGo Inc. (DCGO) | United States | $0.034B | -0.25 |
| VSEE HEALTH, INC. (VSEE) | United States | $0.003B | |
| Agape ATP Corp (ATPC) | $0.002B | ||
| Privia Health Group, Inc. (PRVA) | United States | $2.477B | 115.52 |
| GeneDx Holdings Corp. (WGS) | United States | $2.638B | -19.23 |
| LifeStance Health Group, Inc. (LFST) | United States | $4.510B | 80.86 |